https://knews.kathimerini.com.cy/en/news/livestock-vaccination-campaign-moves-to-second-phase-following-first-dose-rollout
Veterinary authorities report steady progress in efforts to contain the recent outbreak of foot-and-mouth disease, with no new cases recorded and the number of affected livestock units holding at 42....
https://knews.kathimerini.com.cy/en/news/foot-and-mouth-battle-intensifies-threatening-farms-and-food-prices
The fight against foot-and-mouth disease continues to escalate in the Larnaca district, with the situation taking increasingly worrying proportions in recent weeks. ...
https://knews.kathimerini.com.cy/en/news/flu-a-hits-hard-across-cyprus-as-winter-viruses-circulate
Flu A is running high across Cyprus this winter, with other viruses such as RSV and adenovirus also circulating, health experts say....
https://knews.kathimerini.com.cy/en/news/cyprus-rolls-out-new-treatment-to-protect-babies-from-dangerous-winter-virus
Cyprus’ Health Ministry has introduced a new preventive treatment for respiratory syncytial virus (RSV), aiming to cut hospital admissions among infants and young children during the upcoming winter season....
https://knews.kathimerini.com.cy/en/news/highly-infectious-bird-flu-threatens-seals-in-antarctica
Scientists are on high alert as a virus shows ominous signs of moving between birds and mammals, sparking concerns of potential mutations in 'spillover events.'...
https://knews.kathimerini.com.cy/en/news/what-immunologists-say-about-covid-shot-side-effects
It's officially fall, and that means pumpkin spice lattes are back—and that a new COVID-19 booster is available....
https://knews.kathimerini.com.cy/en/news/promising-drug-slows-alzheimer-s-decline-by-36
A new drug that claims to slow mental decline caused by Alzheimer's by 36 percent could spell 'the beginning of the end' for the degenerative brain disease....
https://knews.kathimerini.com.cy/en/news/doctor-‘fake-pass-trial-put-off-again
A Cypriot doctor, who denies ever issuing bogus vaccination certificates during the pandemic, will have to wait a whole year before his day in court, after a judge on Monday pushed back his trial until next year...
https://knews.kathimerini.com.cy/en/news/uk-approves-first-drug-that-prevents-covid
A first-of-its-kind drug that stops people from catching Covid has been approved in the UK by the country's medical watchdog....
https://knews.kathimerini.com.cy/en/news/study-certain-blood-types-may-be-more-or-less-vulnerable-to-covid
Blood type doesn’t affect much in our daily lives. In fact, most people don’t even know whether they’re Type A, B, AB, or O. But the seemingly-banal detail might be a factor in who comes under the thumb of 2020’s worldwide tyrant—that is, coronavirus....
https://knews.kathimerini.com.cy/en/news/covid-boosters-continue-to-protect-most-people-for-many-months-perhaps-years
According to a flurry of new studies, it looks as if Covid boosters will continue to protect most people from serious illness and death for many months, and perhaps even years — which means we probably won’t need to line up for another shot anytime soon....
https://knews.kathimerini.com.cy/en/news/who-is-dr-robert-malone-and-what-is-the-controversy-surrounding-his-statements-on-mrna-vaccines
Robert Malone, the self-proclaimed inventor of mRNA vaccines and a skeptic of the COVID-19 vaccines that use mRNA technology, has skyrocketed to celebrity status in recent months....
https://knews.kathimerini.com.cy/en/news/coronavirus-research-shows-antibodies-in-99-of-cases-even-20-months-later
Coronavirus antibodies show up even 20 months after the disease in almost all organisms that survive Covid-19, according to a new US study. But it is not clear whether they protect against new infections, especially with newer mutations....
https://knews.kathimerini.com.cy/en/news/coronavirus-which-patients-are-at-risk-of-long-covid-19
Scientists in Switzerland have announced that for the first time they have found a way to predict whether a patient is at risk of developing the so-called long Covid-19,
...
https://knews.kathimerini.com.cy/en/news/cypriot-study-finds-more-antibodies-in-specific-groups
A study by the University of Cyprus suggests people over 60, men, and persons who developed symptoms were more likely to have a higher count in lgG antibodies, with scientists hoping a second phase of the research would tackle antibody count after vaccination...
https://knews.kathimerini.com.cy/en/news/fully-vaccinated-cypriots-show-higher-antibody-levels-than-those-infected
Preliminary data from an ongoing study in Cyprus show that antibody levels following vaccination with the first and second dose against COVID-19 are at much higher levels than on people who were infected with the disease,...
https://knews.kathimerini.com.cy/en/news/omicron-how-protected-are-those-who-have-become-ill-and-been-vaccinated
On December 13, 2021, an article was published in the prestigious journal Nature showing that although the combination of natural infection with SARS-CoV-2 along with vaccination (hybrid immunity) provides strong protection against the new coronavirus, a recent analysis of a large number of individuals from Israel argues...
https://knews.kathimerini.com.cy/en/news/full-vaccination-plus-breakthrough-infection-equals-super-immunity
A study by Oregon researchers finds that people fully vaccinated against COVID-19 who have a breakthrough infection end up with what the authors call "super immunity."...
https://knews.kathimerini.com.cy/en/news/who-omicron-poses-very-high-global-risk-world-must-prepare
The Omicron coronavirus variant is likely to spread internationally, posing a "very high" global risk of infection surges that could have "severe consequences" in some areas, the World Health Organisation (WHO) said on Monday....
https://knews.kathimerini.com.cy/en/news/monoclonal-antibody-treatment-for-covid-expected-in-cyprus-any-day-now
The arrival of monoclonal antibody therapies in Cyprus is just a matter of time, according to the Deputy Director of Pharmaceutical Services of the Ministry of Health, Dr. Elena Panagiotopoulou....
https://knews.kathimerini.com.cy/en/news/vaccine-safe-pass-in-doubt-over-waning-immunity
The health ministry in the Republic of Cyprus is scrambling to contain a possible spike in COVID cases this winter, with officials reportedly favoring a required third dose for individuals who want to use their vaccination status as a Safe Pass...
https://knews.kathimerini.com.cy/en/news/regeneron-antibody-cocktail-protects-for-up-to-eight-months
Regeneron reported that a dose of the antibody cocktail it makes reduced the risk of COVID-19 infection by 81.6% for two to eight months after administration of the drug in a final trial....
https://knews.kathimerini.com.cy/en/news/cancer-vaccines-in-two-to-three-years
Drs. Ugur Sahin and Ozlem Tureci are a very modest, perhaps even humble, scientist couple. ...
https://knews.kathimerini.com.cy/en/news/astrazeneca-s-antibody-cocktail-successful-in-treating-covid-19
AstraZeneca has asked US regulators to grant an emergency use authorization for its antibody therapy drug called AZD7442....
https://knews.kathimerini.com.cy/en/news/police-puzzled-over-test-results-in-fake-vax-probe
Police investigators probing allegations that a doctor issued fake vaccination certificates are puzzled by a number of his patients, who insist they were vaccinated by the suspect despite showing a low count in antibody tests...
https://knews.kathimerini.com.cy/en/news/stella-kyriakidou
The Commissioner for Health and Food Safety, Stella Kyriakides, will be in Cyprus on Friday, September 24, for meetings,...
https://knews.kathimerini.com.cy/en/news/j-j-says-second-shot-boosts-protection-for-moderate-severe-covid-19-to-94
Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease....
https://knews.kathimerini.com.cy/en/news/pfizer-produces-strong-antibodies-in-kids
Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was safe and produced strong antibody responses in children ages 5 to 11 in a large-scale trial,...
https://knews.kathimerini.com.cy/en/news/johnson-johnson-vaccine-is-a-booster-shot-necessary
The New York Times answers questions about J&J booster shots...
https://knews.kathimerini.com.cy/en/news/fake-vaccination-certificates
Police are investigating several cases of forged vaccination certificates allegedly issued by a doctor in Larnaca....
